1-[2-(甲氧基甲基)苯基]-1-乙酮 、 2-氨甲基吡啶 、 对甲苯磺酸一水合物 以to give the title compound as a yellow oil (276 mg, 86%)的产率得到1-[2-(methoxymethyl)phenyl]-N-(pyridin-2-ylmethyl)ethanamine
The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.